BioAge Labs co-founder and CEO Kristen Fortney explains why her company chose to start with finding treatments for diseases that are familiar to regulatory systems and potential payers, while maintaining a broader long-term vision.
BioAge Labs co-founder and CEO Kristen Fortney explains why her company chose to start with finding treatments for diseases that are familiar to regulatory systems and potential payers, while maintaining a broader long-term vision.